Delivery Order SPE2DB22D1106-SPE2DB25FEKL8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a ceiling value of $16,198.68. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively awarded. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a ceiling value of $2,147.09 under firm fixed pricing. This delivery order, which is not set-aside designated, represents a competitive award to the prime contractor and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $7,201.22 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed-price contract, with a completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involved no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a $7,807.46 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injections). This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $16,156.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 18, 2025, valued at $20,560.37 for the supply of Forteo (560 mcg/2.24 mL pen injections) to support the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed price with no set-aside designation, and performance is scheduled for completion by September 19, 2025, with the place of performance located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $42,885.60 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price contract, with an ultimate completion date of August 7, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injection) valued at $4,239.43 with a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEKL8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections valued at $17,159.56. This firm fixed-price delivery order, with an ultimate completion date of April 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award was made on a non-set-aside, competitively awarded basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for Forteo, an osteoporosis treatment, exemplifies the company's role in fulfilling the broader DLA Pharmaceutical Prime Vendor Global Program, which enables the distribution of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 4/24/25 |